Kontour (Xi'an) Medical Technology Co. Ltd.

Kontour Medical released its 2026 interim report, with total operating revenue of 171 million yuan and net profit attributable to the parent of 41.39 million yuan, down 24.74% from the same period last year. Net cash inflow from operating activities was 59.61 million yuan, down 4.15% year-on-year. The company's asset-liability ratio was 19.23%, gross margin was 77.35%, ROE was 5.55%, and diluted earnings per share was 0.51 yuan. The number of shareholders was 4,008, and the top ten shareholders held 67.92% of the shares.

Kontour Medical released its 2026 interim report. Net profit attributable to the parent in the first half was 41.39 million yuan, down 24.7% year on year, while operating revenue was 171 million yuan, up 0.4% year on year. Second-quarter operating revenue was 97.28 million yuan, up 10.8% year on year, and net profit attributable to the parent was 28.23 million yuan, down 8.8% year on year. The company's neurosurgery business achieved operating revenue of 146 million yuan, down 2.26% year on year, of which PEEK material product revenue was 113 million yuan, up 4.06% year on year. Cardiothoracic surgery business revenue was 6.36 million yuan, down 45.86% year on year, affected by volume-based procurement and intensifying competition. Maxillofacial repair business revenue was 11.56 million yuan, up 128.23% year on year. As of the end of the second quarter, the company's total assets were 932 million yuan, up 2.5% from the end of the previous year, and net assets attributable to the parent were 746 million yuan, up 3.9%.

Kontour Medical announced that Xi'an Heying Enterprise Management Consulting Partnership, a concert party of the controlling shareholder and actual controller, has cumulatively reduced its stake by 720,000 shares through centralized competitive trading, representing 0.88% of the company's total share capital. Following the reduction, Xi'an Heying's shareholding decreased from 3.12 million shares to 2.4 million shares, with its ownership ratio falling from 3.82% to 2.94%. The combined shareholding ratio of the concert parties declined from 53.67% to 52.80%. In the first quarter of 2026, the company achieved revenue of 73.68 million yuan and net profit attributable to the parent of 13.16 million yuan.